Lumos Pharma (NASDAQ:LUMO) reported its Q4 earnings results on Thursday, March 7, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Lumos Pharma missed estimated earnings by -2.0%, reporting an EPS of $-1.17 versus an estimate of $-1.15.
Revenue was up $314 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11 which was followed by a 11.0% increase in the share price the next day.
Here's a look at Lumos Pharma's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -1.15 | -1.10 | -1.12 | -0.93 |
| EPS Actual | -1.04 | -1.09 | -0.89 | -0.98 |
| Revenue Estimate | 320K | 410K | 180K | 110K |
| Revenue Actual | 7K | 527K | 691K | 512K |
To track all earnings releases for Lumos Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.